Ciprofloxacin - Original BioMedicals

Drug Profile

Ciprofloxacin - Original BioMedicals

Alternative Names: A 03; CCM-ciprofloxacin

Latest Information Update: 21 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Original BioMedicals
  • Class Antibacterials; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Gram-negative infections; Gram-positive infections

Most Recent Events

  • 21 Jul 2016 Chemical structure information added
  • 21 Jul 2016 Preclinical trials in Gram-negative infections in Taiwan (unspecified route)
  • 21 Jul 2016 Preclinical trials in Gram-positive infections in Taiwan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top